Home   Chapter Home   Jobs   Conferences   Fellowships   Books



Advertisement

Colon tumor

Carcinoma

Neuroendocrine carcinoma


Reviewers: Charanjeet Singh, M.D. (see Reviewers page)
Revised: 23 May 2012, last major update May 2012
Copyright: (c) 2003-2012, PathologyOutlines.com, Inc.

General
=========================================================================

● This discussion excludes carcinoid tumors and small cell carcinoma
● Rare; highly aggressive with nodal metastases (Am J Surg Pathol 1990;14:1010, Dis Colon Rectum 2004;47:163)
● Often high stage at diagnosis (Dis Colon Rectum 2004;47:163)
● Mixed neuroendocrine carcinoma-adenocarcinoma also occurs (Virchows Arch 2006;448:644)

Micro description
=========================================================================

● Organoid appearance, larger cells than small cell carcinoma, marked nuclear pleomorphism, large irregular hyperchromatic nuclei with prominent nucleoli, frequent mitotic activity and tumor necrosis

Micro images
=========================================================================



Rectal tumor

       
Concurrent large cell neuroendocrine carcinoma (ulcerative fungating mass) and adenocarcinoma (polypoid mass)

Ampulla of Vater

H&E, chromogranin

Cervix

Trabecular pattern with mitotic activity

Positive stains
=========================================================================

● Cytokeratin, usually EMA, NSE, chromogranin and synaptophysin
● c-kit/CD117 in 23% but not associated with activating mutations (Am J Surg Pathol 2003;27:1551)

Differential diagnosis
=========================================================================

● Focal neuroendocrine cells in adenocarcinoma: more common (Arch Pathol Lab Med 1998;122:912)
● Glandular-neuroendocrine mixed tumor: either composite or collision tumors (Am J Surg Pathol 2011;35:413)

Additional references
=========================================================================

Korean J Gastroenterol 2006;48:97

End of Colon tumor > Carcinoma > Neuroendocrine carcinoma


This information is intended for physicians and related personnel, who understand that medical information is often imperfect, and must be interpreted in the context of a patient's clinical data using reasonable medical judgment. This website should not be used as a substitute for the advice of a licensed physician.

All information on this website is protected by copyright of PathologyOutlines.com, Inc. Information from third parties may also be protected by copyright. Please contact us at copyrightPathOut@gmail.com with any questions (click here for other contact information).